Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 3, 2017
Real-World Management of Trabectedin/Pegylated Liposomal Doxorubicin in Platinum-Sensitive Recurrent Ovarian Cancer Patients: A National SurveyGabriella Ferrandina, Giulia Amadio, Ida Paris, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 22, 2021
Medical treatment of patients with gynecologic cancer during the COVID-19 pandemicEleonora Palluzzi, Giacomo Corrado, Claudia Marchetti, et al.Gynecologic Oncology|May 9, 2006
Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: association with pathological response to treatment and clinical outcomeGabriella Ferrandina, Mariagrazia Distefano, Daniela Smaniotto, et al.Minerva Medica|May 25, 2019
New medical approaches in advanced ovarian cancerGiacomo Corrado, Eleonora Palluzzi, Carolina Bottoni, et al.Current Medicinal Chemistry. Anti-Cancer Agents|April 8, 2003
Second generation taxanes: from the natural framework to the challenge of drug resistanceCristiano Ferlini, Iwao Ojima, Mariagrazia Distefano, et al.Life Sciences|March 9, 2002
Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo the activity of cisplatinSabrina Giacomelli, Daniela Gallo, Patrizia Apollonio, et al.Gynecologic Oncology|April 10, 2022
The impact of secondary cytoreductive surgery in platinum sensitive recurrent ovarian cancer treated with upfront neoadjuvant chemotherapy and interval debulking surgeryNicolò Bizzarri, Claudia Marchetti, Carmine Conte, et al.Journal of Gynecologic Oncology|December 3, 2019
ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experienceGiulia Amadio, Claudia Marchetti, Emanuele Rocco Villani, et al.Molecular Pharmacology|June 20, 2003
Bcl-2 down-regulation is a novel mechanism of paclitaxel resistanceCristiano Ferlini, Giuseppina Raspaglio, Simona Mozzetti, et al.BMC Cancer|December 16, 2014
Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter studyGabriella Ferrandina, Giacomo Corrado, Floriana Mascilini, et al.Pageof 3